CCRCC
Clinical trials for CCRCC explained in plain language.
Never miss a new study
Get alerted when new CCRCC trials appear
Sign up with your email to follow new studies for CCRCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo tackles kidney cancer that came back after immunotherapy
Disease control Not yet recruitingThis study tests whether combining two drugs, pembrolizumab and lenvatinib, can help people with advanced kidney cancer (clear cell type) whose cancer returned after prior immunotherapy. About 108 adults will receive the combination to see if it shrinks tumors or delays cancer gr…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New PET scan could spot hidden kidney cancer after treatment
Diagnosis Not yet recruitingThis study tests whether a special PET scan using a drug called 89Zr-girentuximab can detect kidney cancer that remains or comes back after initial treatment. Ten adults with clear cell renal cell carcinoma will receive the drug and then have a PET scan. Some will also have a sec…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC